Understand the debate surrounding medical fraud in South Africa: Did the Section 59 inquiry focus too much on race?
You must be a subscriber to access all of this content.
An African form of type 1 diabetes challenges existing beliefs about the autoimmune response and its management.
You must be a subscriber to access all of this content.
...
You must be a subscriber to access all of this content.
Adcock Ingram is set to delist from the JSE as Natco Pharma partners with Bidvest in a major take-private deal.
You must be a subscriber to access all of this content.
The NHI dream promises universal health coverage but faces staggering costs. Discover the financial hurdles ahead.
You must be a subscriber to access all of this content.
Analyze the claims made in the racial bias report and how they impact perceptions of fairness in medical scheme fraud.
You must be a subscriber to access all of this content.